+7 (701) 759 90 19
USD 433.55 EUR 515.53
RUB 5.62 CNY 66.25
News

UK to fund study on 3rd dose of COVID-19 vaccine

4 March 2021 13:16
Share in:
UK to fund study on 3rd dose of COVID-19 vaccine

LONDON. KAZINFORM - The British government will fund what it believes to be the world's first study assessing the effectiveness of a third dose of vaccine to combat COVID-19, the UK Budget revealed on Wednesday, Xinhua reports.

Related news
35,821 treated for COVID-19 in Kazakhstan Kazakhstan reports 130 cases of COVID-19-like pneumonia in past day Daily number of COVID-19 recoveries at 1,584 in Kazakhstan

The government is committing 22 million pounds (30.70 million U.S. dollars) to studies that test the effectiveness of a combination of different COVID-19 vaccines. This will also fund the world's first study assessing the effectiveness of a third dose of vaccine to improve the response against current and future variants of COVID-19, according to the Budget.

It said 28 million pounds (39.07 million dollars) will be invested to increase the country's capacity for vaccine testing, support for clinical trials and improve its ability to rapidly acquire samples of new variants of COVID-19.

The Budget said there will be an extra 1.65 billion pounds (2.30 billion dollars) of cash injection to ensure the COVID-19 vaccination rollout in England continues to be a success.

Britain started its COVID-19 vaccination program in December, and over 20 million people had received at least the first dose of a vaccine by the end of February.



Share in:
Related news
+7
Send
Employees online
Editor
Nurmaganbetova Zhanna
Nurmaganbetova Zhanna
954-048
Editor
Kudrenok Tatyana
Kudrenok Tatyana
954-048
Editor
Seilkhanov Adlet
Seilkhanov Adlet
954-048

Archive